Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs f…
Biotechnology
US, Cranbury [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer Group
Configuration
| Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 13,028.85 | 856.80 | 209.13 | -132.92 | 37.64 | 0.00 | 19.5333 | -0.36 | -1.0388 | -22.4403 | -0.08 | -0.07 | 7.4640 | - - | ||
| Maximum | - - | - - | - - | 458,604.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.01 | 1,336.3467 | 6.70 | 3.0051 | 85.3485 | 0.38 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0007 | - - | ||
| Rocket Pharmaceuticals, Inc. RCKT | 13.98 | -0.84 -5.67% | 1,130 vs. 846 | 1,274.00 | 0.00 | -62.00 | -58.00 | -1,021.00 | -0.6600 | -10.0705 | 0.0000 | 0.0000 | 0.0000 | -0.1406 | -0.1242 | 10.2835 | 91.00 | ||
| Cytokinetics, Incorporated CYTK | 50.22 | -4.48 -8.19% | 2,342 vs. 1,170 | 5,926.00 | 0.00 | -135.00 | -127.00 | -2,247.00 | -1.3300 | -13.7171 | 0.0000 | -1.7916 | -162.4467 | 0.3424 | -0.1679 | 6.9796 | 118.00 | ||
| Vaxcyte, Inc. PCVX | 86.83 | -5.85 -6.31% | 4,600 vs. 1,091 | 10,822.00 | 0.00 | -95.00 | -171.00 | -1,019.00 | -0.8500 | -19.6094 | 0.0000 | 0.0000 | 0.0000 | -0.0479 | -0.0454 | 17.2498 | 124.00 | ||
| Rhythm Pharmaceuticals, Inc. RYTM | 56.23 | -3.54 -5.92% | 677 vs. 473 | 3,455.00 | 25.00 | -141.00 | -80.00 | -1,036.00 | -2.3500 | -4.5393 | 0.0000 | 0.8845 | -5.4443 | -2.2957 | -0.5466 | 3.9862 | 61.00 | ||
| Revolution Medicines, Inc. RVMD | 55.13 | -2.24 -3.90% | 1,944 vs. 1,156 | 9,273.00 | 0.00 | -116.00 | -163.00 | -1,253.00 | -0.7000 | -11.2467 | 0.0000 | 0.0000 | 0.0000 | -0.0672 | -0.0608 | 18.1763 | 168.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.